Aurinia shares underperformed the S&P 500 gain in late July 2025.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Aurinia shares underperformed the S&P 500 gain in late July 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Aurinia (Canada)
company in Victoria, Canada
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksAurinia Pharmaceuticals (AUPH) Q2 Earnings Miss Estimates Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.16 per share, missing the Zacks Consensus Estimate of $0.17 per share.